{
  "DOI": "10.1038/s41431-017-0021-2",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-017-0021-2",
  "alternative-id": [
    "21"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "5 June 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "20 September 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "22 September 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "8 November 2017"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Golmard",
      "given": "Lisa",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Castéra",
      "given": "Laurent",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Krieger",
      "given": "Sophie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Moncoutier",
      "given": "Virginie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Abidallah",
      "given": "Khadija",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tenreiro",
      "given": "Henrique",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Laugé",
      "given": "Anthony",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tarabeux",
      "given": "Julien",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Millot",
      "given": "Gael A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nicolas",
      "given": "André",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Laé",
      "given": "Marick",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Abadie",
      "given": "Caroline",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berthet",
      "given": "Pascaline",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Polycarpe",
      "given": "Florence",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Frébourg",
      "given": "Thierry",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Elan",
      "given": "Camille",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Pauw",
      "given": "Antoine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gauthier-Villars",
      "given": "Marion",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buecher",
      "given": "Bruno",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8100-2272",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Stern",
      "given": "Marc-Henri",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stoppa-Lyonnet",
      "given": "Dominique",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vaur",
      "given": "Dominique",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Houdayer",
      "given": "Claude",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        11,
        8
      ]
    ],
    "date-time": "2017-11-08T15:05:28Z",
    "timestamp": 1510153528000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:41:22Z",
    "timestamp": 1684618882000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        21
      ]
    ],
    "date-time": "2024-02-21T09:41:33Z",
    "timestamp": 1708508493955
  },
  "is-referenced-by-count": 37,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "12",
  "issued": {
    "date-parts": [
      [
        2017,
        11,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2017,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            11,
            8
          ]
        ],
        "date-time": "2017-11-08T00:00:00Z",
        "timestamp": 1510099200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-017-0021-2",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-017-0021-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-017-0021-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1345-1353",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2017,
        11,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        11,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/jnci/djt095",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "812",
      "journal-title": "J Natl Cancer Inst",
      "key": "21_CR1",
      "unstructured": "Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–22.",
      "volume": "105",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "journal-title": "N Engl J Med",
      "key": "21_CR2",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371:497–506.",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.5495",
      "author": "BM Norquist",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "JAMA Oncol",
      "key": "21_CR3",
      "unstructured": "Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482–90.",
      "volume": "2",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmedgenet-2015-103529",
      "author": "DF Easton",
      "doi-asserted-by": "publisher",
      "first-page": "298",
      "journal-title": "J Med Genet",
      "key": "21_CR4",
      "unstructured": "Easton DF, Lesueur F, Decker B, et al. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet. 2016;53:298–309.",
      "volume": "53",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.gde.2015.07.002",
      "author": "M Bogliolo",
      "doi-asserted-by": "publisher",
      "first-page": "32",
      "journal-title": "Curr Opin Genet Dev",
      "key": "21_CR5",
      "unstructured": "Bogliolo M, Surrallés J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr Opin Genet Dev. 2015;33:32–40.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1101/cshperspect.a016600",
      "author": "R Prakash",
      "doi-asserted-by": "publisher",
      "first-page": "a016600",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "21_CR6",
      "unstructured": "Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015;7:a016600.",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.569",
      "author": "A Meindl",
      "doi-asserted-by": "publisher",
      "first-page": "410",
      "journal-title": "Nat Genet",
      "key": "21_CR7",
      "unstructured": "Meindl A, Hellebrand H, Wiek C, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42:410–14.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.893",
      "author": "C Loveday",
      "doi-asserted-by": "publisher",
      "first-page": "879",
      "journal-title": "Nat Genet",
      "key": "21_CR8",
      "unstructured": "Loveday C, Turnbull C, Ramsay E, et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet. 2011;43:879–82.",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.2224",
      "author": "C Loveday",
      "doi-asserted-by": "publisher",
      "first-page": "475",
      "journal-title": "Nat Genet",
      "key": "21_CR9",
      "unstructured": "Loveday C, Turnbull C, Ruark E, et al. Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat Genet. 2012;44:475–76. author reply 476",
      "volume": "44",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2407-13-484",
      "author": "L Golmard",
      "doi-asserted-by": "publisher",
      "first-page": "484",
      "journal-title": "BMC Cancer",
      "key": "21_CR10",
      "unstructured": "Golmard L, Caux-Moncoutier V, Davy G, et al. Germline mutation in the RAD51B gene confers predisposition to breast cancer. BMC Cancer. 2013;13:484.",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2015.61.2408",
      "author": "H Song",
      "doi-asserted-by": "publisher",
      "first-page": "2901",
      "journal-title": "J Clin Oncol",
      "key": "21_CR11",
      "unstructured": "Song H, Dicks E, Ramus SJ, et al. Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population. J Clin Oncol. 2015;33:2901–7.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ajhg.2012.02.027",
      "author": "DJ Park",
      "doi-asserted-by": "publisher",
      "first-page": "734",
      "journal-title": "Am J Hum Genet",
      "key": "21_CR12",
      "unstructured": "Park DJ, Lesueur F, Nguyen-Dumont T, et al. Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet. 2012;90:734–39.",
      "volume": "90",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmedgenet-2012-101191",
      "author": "FS Hilbers",
      "doi-asserted-by": "publisher",
      "first-page": "618",
      "journal-title": "J Med Genet",
      "key": "21_CR13",
      "unstructured": "Hilbers FS, Wijnen JT, Hoogerbrugge N, et al. Rare variants in XRCC2 as breast cancer susceptibility alleles. J Med Genet. 2012;49:618–20.",
      "volume": "49",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s40064-015-0880-3",
      "author": "LM Pelttari",
      "doi-asserted-by": "publisher",
      "first-page": "92",
      "journal-title": "SpringerPlus",
      "key": "21_CR14",
      "unstructured": "Pelttari LM, Kiiski JI, Ranta S, et al. RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families. SpringerPlus. 2015;4:92.",
      "volume": "4",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s11033-011-1308-y",
      "author": "XF He",
      "doi-asserted-by": "publisher",
      "first-page": "5125",
      "journal-title": "Mol Biol Rep",
      "key": "21_CR15",
      "unstructured": "He X-F, Wei W, Su J, et al. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies. Mol Biol Rep. 2012;39:5125–34.",
      "volume": "39",
      "year": "2012"
    },
    {
      "author": "C Yuan",
      "first-page": "648137",
      "journal-title": "Biomed Res Int",
      "key": "21_CR16",
      "unstructured": "Yuan C, Liu X, Yan S, Wang C, Kong B. Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk. Biomed Res Int. 2014;2014:648137.",
      "volume": "2014",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ejhg.2014.16",
      "author": "L Castéra",
      "doi-asserted-by": "publisher",
      "first-page": "1305",
      "journal-title": "Eur J Hum Genet",
      "key": "21_CR17",
      "unstructured": "Castéra L, Krieger S, Rousselin A, et al. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet. 2014;22:1305–13.",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "21_CR18",
      "unstructured": "Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmg.2005.033878",
      "author": "SV Tavtigian",
      "doi-asserted-by": "publisher",
      "first-page": "295",
      "journal-title": "J Med Genet",
      "key": "21_CR19",
      "unstructured": "Tavtigian SV, Deffenbaugh AM, Yin L, et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43:295–05.",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1002/humu.22101",
      "author": "C Houdayer",
      "doi-asserted-by": "publisher",
      "first-page": "1228",
      "journal-title": "Hum Mutat",
      "key": "21_CR20",
      "unstructured": "Houdayer C, Caux-Moncoutier V, Krieger S, et al. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat. 2012;33:1228–38.",
      "volume": "33",
      "year": "2012"
    },
    {
      "author": "EB Claus",
      "first-page": "232",
      "journal-title": "Am J Hum Genet",
      "key": "21_CR21",
      "unstructured": "Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991;48:232–42.",
      "volume": "48",
      "year": "1991"
    },
    {
      "DOI": "10.1128/MCB.00465-12",
      "author": "J Chun",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Mol Cell Biol",
      "key": "21_CR22",
      "unstructured": "Chun J, Buechelmaier ES, Powell SN. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol Cell Biol. 2013;33:387–95.",
      "volume": "33",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-12-0950",
      "author": "A Min",
      "doi-asserted-by": "publisher",
      "first-page": "865",
      "journal-title": "Mol Cancer Ther",
      "key": "21_CR23",
      "unstructured": "Min A, Im S-A, Yoon Y-K, et al. RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib. Mol Cancer Ther. 2013;12:865–77.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.23019",
      "author": "FS Hilbers",
      "doi-asserted-by": "publisher",
      "first-page": "914",
      "journal-title": "Hum Mutat",
      "key": "21_CR24",
      "unstructured": "Hilbers FS, Luijsterburg MS, Wiegant WW, et al. Functional analysis of missense variants in the putative breast cancer susceptibility gene XRCC2. Hum Mutat. 2016;37:914–25.",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-17-0190",
      "author": "B Rivera",
      "doi-asserted-by": "publisher",
      "first-page": "4517",
      "journal-title": "Cancer Res",
      "key": "21_CR25",
      "unstructured": "Rivera B, Di Iorio M, Frankum J, et al. Functionally null RAD51D missense mutation associates strongly with ovarian carcinoma. Cancer Res. 2017;77:4517–29.",
      "volume": "77",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10689-014-9747-y",
      "author": "LB Ahlborn",
      "doi-asserted-by": "publisher",
      "first-page": "129",
      "journal-title": "Fam Cancer",
      "key": "21_CR26",
      "unstructured": "Ahlborn LB, Steffensen AY, Jønson L, et al. Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations. Fam Cancer. 2015;14:129–33.",
      "volume": "14",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0058350",
      "author": "J Long",
      "doi-asserted-by": "publisher",
      "first-page": "e58350",
      "journal-title": "PLoS ONE",
      "key": "21_CR27",
      "unstructured": "Long J, Zhang B, Signorello LB, et al. Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. PLoS ONE. 2013;8:e58350.",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1093/carcin/bgt404",
      "author": "KS Purrington",
      "doi-asserted-by": "publisher",
      "first-page": "1012",
      "journal-title": "Carcinogenesis",
      "key": "21_CR28",
      "unstructured": "Purrington KS, Slager S, Eccles D, et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis. 2014;35:1012–19.",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cncr.30498",
      "author": "SS Buys",
      "doi-asserted-by": "publisher",
      "first-page": "1721",
      "journal-title": "Cancer",
      "key": "21_CR29",
      "unstructured": "Buys SS, Sandbach JF, Gammon A, et al. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721–30.",
      "volume": "123",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-1029-3",
      "author": "SR Lakhani",
      "doi-asserted-by": "publisher",
      "first-page": "2473",
      "journal-title": "Clin Cancer Res",
      "key": "21_CR30",
      "unstructured": "Lakhani SR, Manek S, Penault-Llorca F, et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res. 2004;10:2473–81.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s00428-014-1619-1",
      "author": "H Gevensleben",
      "doi-asserted-by": "publisher",
      "first-page": "365",
      "journal-title": "Virchows Arch Int J Pathol",
      "key": "21_CR31",
      "unstructured": "Gevensleben H, Bossung V, Meindl A, et al. Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers. Virchows Arch Int J Pathol. 2014;465:365–69.",
      "volume": "465",
      "year": "2014"
    },
    {
      "DOI": "10.1093/hmg/ddr368",
      "author": "JD Figueroa",
      "doi-asserted-by": "publisher",
      "first-page": "4693",
      "journal-title": "Hum Mol Genet",
      "key": "21_CR32",
      "unstructured": "Figueroa JD, Garcia-Closas M, Humphreys M, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the breast cancer association consortium. Hum Mol Genet. 2011;20:4693–06.",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-11-1266",
      "author": "KN Stevens",
      "doi-asserted-by": "publisher",
      "first-page": "6240",
      "journal-title": "Cancer Res",
      "key": "21_CR33",
      "unstructured": "Stevens KN, Vachon CM, Lee AM, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res. 2011;71:6240–49.",
      "volume": "71",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ng.353",
      "author": "G Thomas",
      "doi-asserted-by": "publisher",
      "first-page": "579",
      "journal-title": "Nat Genet",
      "key": "21_CR34",
      "unstructured": "Thomas G, Jacobs KB, Kraft P, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41:579–84.",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng.2417",
      "author": "N Orr",
      "doi-asserted-by": "publisher",
      "first-page": "1182",
      "journal-title": "Nat Genet",
      "key": "21_CR35",
      "unstructured": "Orr N, Lemnrau A, Cooke R, et al. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet. 2012;44:1182–84.",
      "volume": "44",
      "year": "2012"
    },
    {
      "DOI": "10.1093/hmg/dds115",
      "author": "A Osorio",
      "doi-asserted-by": "publisher",
      "first-page": "2889",
      "journal-title": "Hum Mol Genet",
      "key": "21_CR36",
      "unstructured": "Osorio A, Endt D, Fernández F, et al. Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. Hum Mol Genet. 2012;21:2889–98.",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1399-0004.2012.01917.x",
      "author": "F Coulet",
      "doi-asserted-by": "publisher",
      "first-page": "332",
      "journal-title": "Clin Genet",
      "key": "21_CR37",
      "unstructured": "Coulet F, Fajac A, Colas C, et al. Germline RAD51C mutations in ovarian cancer susceptibility. Clin Genet. 2013;83:332–36.",
      "volume": "83",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.21625",
      "author": "ER Thompson",
      "doi-asserted-by": "publisher",
      "first-page": "95",
      "journal-title": "Hum Mutat",
      "key": "21_CR38",
      "unstructured": "Thompson ER, Boyle SE, Johnson J, et al. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat. 2012;33:95–99.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-014-3078-4",
      "author": "A Blanco",
      "doi-asserted-by": "publisher",
      "first-page": "133",
      "journal-title": "Breast Cancer Res Treat",
      "key": "21_CR39",
      "unstructured": "Blanco A, Gutiérrez-Enríquez S, Santamariña M, et al. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families. Breast Cancer Res Treat. 2014;147:133–43.",
      "volume": "147",
      "year": "2014"
    },
    {
      "DOI": "10.1186/bcr3589",
      "author": "G Schnurbein",
      "doi-asserted-by": "publisher",
      "first-page": "R120",
      "journal-title": "Breast Cancer Res",
      "key": "21_CR40",
      "unstructured": "Schnurbein G, Hauke J, Wappenschmidt B, et al. RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families. Breast Cancer Res. 2013;15:R120.",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10549-011-1677-x",
      "author": "M Vuorela",
      "doi-asserted-by": "publisher",
      "first-page": "1003",
      "journal-title": "Breast Cancer Res Treat",
      "key": "21_CR41",
      "unstructured": "Vuorela M, Pylkäs K, Hartikainen JM, et al. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast Cancer Res Treat. 2011;130:1003–10.",
      "volume": "130",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ijc.28540",
      "author": "S Gutiérrez-Enríquez",
      "doi-asserted-by": "publisher",
      "first-page": "2088",
      "journal-title": "Int J Cancer",
      "key": "21_CR42",
      "unstructured": "Gutiérrez-Enríquez S, Bonache S, de Garibay GR, et al. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants. Int J Cancer. 2014;134:2088–97.",
      "volume": "134",
      "year": "2014"
    },
    {
      "DOI": "10.1038/bjc.2012.87",
      "author": "DJ Osher",
      "doi-asserted-by": "publisher",
      "first-page": "1460",
      "journal-title": "Br J Cancer",
      "key": "21_CR43",
      "unstructured": "Osher DJ, De Leeneer K, Michils G, et al. Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families. Br J Cancer. 2012;106:1460–63.",
      "volume": "106",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.clbc.2014.08.005",
      "author": "JL Baker",
      "doi-asserted-by": "publisher",
      "first-page": "e71",
      "journal-title": "Clin Breast Cancer",
      "key": "21_CR44",
      "unstructured": "Baker JL, Schwab RB, Wallace AM, Madlensky L. Breast cancer in a RAD51D mutation carrier: case report and review of the literature. Clin Breast Cancer. 2015;15:e71–75.",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0091202",
      "author": "Y He",
      "doi-asserted-by": "publisher",
      "first-page": "e91202",
      "journal-title": "PLoS ONE",
      "key": "21_CR45",
      "unstructured": "He Y, Zhang Y, Jin C, et al. Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis. PLoS ONE. 2014;9:e91202.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.4238/2015.September.9.19",
      "author": "M Zhai",
      "doi-asserted-by": "publisher",
      "first-page": "10808",
      "journal-title": "Genet Mol Res",
      "key": "21_CR46",
      "unstructured": "Zhai M, Wang Y, Jiang MF Arg188His polymorphism in the XRCC2 gene and the risk of ovarian cancer: a meta-analysis. Genet Mol Res. 2015;14:10808–815.",
      "volume": "14",
      "year": "2015"
    },
    {
      "author": "M Kamali",
      "first-page": "1743",
      "journal-title": "Asian Pac J Cancer Prev",
      "key": "21_CR47",
      "unstructured": "Kamali M, Hamadani S, Neamatzadeh H, et al. Association of XRCC2rs3218536 polymorphism with susceptibility of breast and ovarian cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2017;18:1743–749.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1111/cge.12548",
      "author": "V Sopik",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Clin Genet",
      "key": "21_CR48",
      "unstructured": "Sopik V, Akbari MR, Narod SA Genetic testing for RAD51C mutations: in the clinic and community. Clin Genet. 2015;88:303–12.",
      "volume": "88",
      "year": "2015"
    },
    {
      "DOI": "10.1038/bjc.2015.394",
      "author": "Y Drew",
      "doi-asserted-by": "publisher",
      "first-page": "S3",
      "journal-title": "Br J Cancer",
      "key": "21_CR49",
      "unstructured": "Drew Y The development of PARP inhibitors in ovarian cancer: from bench to bedside. Br J Cancer. 2015;113:S3–S9.",
      "volume": "113",
      "year": "2015"
    }
  ],
  "reference-count": 49,
  "references-count": 49,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-017-0021-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "25"
}